Nikolaus Seiler
Laboratory of Nutritional Oncology
INSERM U392
IRCAD
BP 426 67091 Strabourg Cedex
France
Name/email consistency: high
- Synergism between apple procyanidins and lysosomotropic drugs: potential in chemoprevention. Seiler, N., Chaabi, M., Roussi, S., Gossé, F., Lobstein, A., Raul, F. Anticancer Res. (2006)
- Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Seiler, N. Pharmacol. Ther. (2005)
- Polyamines and apoptosis. Seiler, N., Raul, F. J. Cell. Mol. Med. (2005)
- Cytotoxicity of the polyamine oxidase inactivator MDL 72527 to cancer cells: comparison with a saturated structural analogue. Seiler, N., Renault, J., Gossé, F., Roussi, S., Raul, F. Int. J. Oncol. (2005)
- Catabolism of polyamines. Seiler, N. Amino. Acids (2004)
- How important is the oxidative degradation of spermine?: minireview article. Seiler, N. Amino. Acids (2004)
- Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasiveness. Seiler, N., Schneider, Y., Gossé, F., Schleiffer, R., Raul, F. Int. J. Oncol. (2004)
- Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Seiler, N. Curr. Drug. Targets (2003)
- Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Seiler, N. Curr. Drug. Targets (2003)
- Ammonia and Alzheimer's disease. Seiler, N. Neurochem. Int. (2002)
- Oxidation of polyamines and brain injury. Seiler, N. Neurochem. Res. (2000)
- Inhibition of polyamine oxidase enhances the cytotoxicity of polyamine oxidase substrates. A model study with N1-(n-octanesulfonyl)spermine and human colon cancer cells. Seiler, N., Duranton, B., Vincent, F., Gossé, F., Renault, J., Raul, F. Int. J. Biochem. Cell Biol. (2000)
- Effect of the polyamine oxidase inactivator MDL 72527 on N(1)-(n-octanesulfonyl)spermine toxicity. Seiler, N., Badolo, L., Duranton, B., Vincent, F., Schneider, Y., Gossé, F., Raul, F. Int. J. Biochem. Cell Biol. (2000)
- Ornithine aminotransferase, a potential target for the treatment of hyperammonemias. Seiler, N. Curr. Drug. Targets (2000)